US Patent 9115086 Therapeutic compositions and related methods of use
Patent 9115086 was granted and assigned to Agios Pharmaceuticals on August, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+214 characters)
Article
Patent abstract
Compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09115086 Therapeutic compositions and related methods of use US Patent 9115086 Therapeutic compositions and related methods of use
Infobox
Patent Number
09115086
Patent Number
9115086
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09115086 Therapeutic compositions and related methods of use
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09115086
Date of patent
August 25, 2015
Patent application number
13339719
Date Filed
December 29, 2011
Patent primary examiner
Find more entities like US Patent 9115086 Therapeutic compositions and related methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
